This compound is a salt form of an active pharmaceutical ingredient impurity, specifically the hemifumarate salt of a bis-substituted aliskiren analog. It is characterized as a highly flexible molecule with multiple hydrogen bond donors and acceptors, consistent with a pharmaceutical impurity standard.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1438401-04-7
Telaglenastat
pharmaceutical raw material
Barbital sodium
pharmaceutical raw material
Trihexyphenidyl
pharmaceutical raw material
Piperazine citrate
pharmaceutical raw material
bis((2S,4S,5S,7S)-5-amino-N-(3-amino-2,2-dimethyl-3-oxopropyl)-4-hydroxy-7-[hydroxy-[4-methoxy-3-(3-methoxypropoxy)phenyl]methyl]-8-methyl-2-propan-2-ylnonanamide);(E)-but-2-enedioic acid
PDYNUEBDJNAXLX-RSHGANEQSA-N
CC(C)[C@H](C[C@@H]([C@H](C[C@@H](C(C)C)C(=O)NCC(C)(C)C(=O)N)O)N)C(C1=CC(=C(C=C1)OC)OCCCOC)O.CC(C)[C@H](C[C@@H]([C@H](C[C@@H](C(C)C)C(=O)NCC(C)(C)C(=O)N)O)N)C(C1=CC(=C(C=C1)OC)OCCCOC)O.C(=C/C(=O)O)\C(=O)O